Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial and viral antigens are diverse molecules, primarily proteins, polysaccharides, or lipids, that are expressed by pathogens and recognized as foreign by the host immune system [2, 11]. These antigens often serve essential roles for the microorganism, such as mediating host cell attachment, facilitating viral entry, or providing structural integrity to the bacterial cell wall [6, 10, 14]. In the host, the recognition of these molecules by B-cell and T-cell receptors triggers an immune cascade, leading to the production of specific antibodies and the activation of cell-mediated defenses [10, 19]. In medical science, these antigens are the fundamental components of vaccines, which use attenuated, inactivated, or subunit forms of the pathogen to induce long-lasting immunological memory [8, 15]. They are also the primary targets for monoclonal antibody therapies, which neutralize pathogens or their secreted toxins to treat active infections [2, 7]. Furthermore, the detection of specific antigens in clinical samples is a cornerstone of diagnostic testing, allowing for the rapid identification of infectious agents [3, 23]. However, targeting these antigens can present challenges, such as the potential for molecular mimicry to induce autoimmune responses or the emergence of antigenically distinct variants that escape existing immunity [12, 17, 21]. Overall, bacterial and viral antigens are central to the interaction between pathogens and the host, forming the basis for most preventive and therapeutic strategies in infectious disease management [12, 13, 17].
Neutralization of pathogens or their secreted toxins to prevent host cell entry and infection, or the induction of adaptive immune memory through controlled exposure to antigenic components in vaccines.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial and viral antigens.